Fulgent Genetics Long-Term Investments 2015-2024 | FLGT

Fulgent Genetics long-term investments from 2015 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
Fulgent Genetics Annual Long-Term Investments
(Millions of US $)
2023 $424
2022 $327
2021 $485
2020 $133
2019 $43
2018 $8
2017 $17
2016 $26
2015 $
2014 $
Fulgent Genetics Quarterly Long-Term Investments
(Millions of US $)
2024-09-30 $602
2024-06-30 $526
2024-03-31 $540
2023-12-31 $424
2023-09-30 $384
2023-06-30 $388
2023-03-31 $367
2022-12-31 $327
2022-09-30 $347
2022-06-30 $416
2022-03-31 $493
2021-12-31 $485
2021-09-30 $407
2021-06-30 $393
2021-03-31 $288
2020-12-31 $133
2020-09-30 $31
2020-06-30 $46
2020-03-31 $44
2019-12-31 $43
2019-09-30 $12
2019-06-30 $13
2019-03-31 $10
2018-12-31 $8
2018-09-30 $6
2018-06-30 $9
2018-03-31 $12
2017-12-31 $17
2017-09-30 $20
2017-06-30 $17
2017-03-31 $20
2016-12-31 $26
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.515B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.714B 55.57
Tempus AI (TEM) United States $7.994B 0.00
Hims & Hers Health (HIMS) United States $6.961B 177.00
Inspire Medical Systems (INSP) United States $5.693B 177.56
IRhythm Technologies (IRTC) United States $3.453B 0.00
Privia Health (PRVA) United States $2.701B 225.10
Enovis (ENOV) United States $2.693B 17.94
Azenta (AZTA) United States $2.440B 130.24
Clover Health Investments (CLOV) United States $2.230B 0.00
Omnicell (OMCL) United States $2.070B 67.71
Schrodinger (SDGR) United States $1.819B 0.00
10x Genomics (TXG) United States $1.796B 0.00
Phreesia (PHR) United States $1.669B 0.00
Butterfly Network (BFLY) United States $0.748B 0.00
Standard BioTools (LAB) United States $0.588B 0.00
Talkspace (TALK) United States $0.537B 0.00
TruBridge (TBRG) United States $0.362B 105.43
Nyxoah SA (NYXH) Belgium $0.354B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Pulmonx (LUNG) United States $0.230B 0.00
American Well (AMWL) United States $0.169B 0.00
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
P3 Health Partners (PIII) United States $0.069B 0.00
CareCloud (CCLD) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
111 (YI) China $0.047B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00